Vestal Point Capital, LP Ventyx Biosciences, Inc. Transaction History
Vestal Point Capital, LP
- $1.4 Trillion
- Q1 2025
A detailed history of Vestal Point Capital, LP transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 2,000,000 shares of VTYX stock, worth $2.42 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
2,000,000
Previous 2,000,000
-0.0%
Holding current value
$2.42 Million
Previous $4.38 Billion
47.49%
% of portfolio
0.16%
Previous 0.26%
Shares
3 transactions
Others Institutions Holding VTYX
# of Institutions
129Shares Held
44.8MCall Options Held
35.2KPut Options Held
40.6K-
Black Rock Inc. New York, NY4.77MShares$5.77 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.23MShares$5.12 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$4.25 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA3.1MShares$3.75 Million0.23% of portfolio
-
Sio Capital Management, LLC New York, NY2.58MShares$3.13 Million1.12% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $68.4M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...